Accessibility Menu
 
Arrow-Thin-Down
S&P 500
7,400.96
-0.2%
-11.88
Arrow-Thin-Down
DJI
49,760.56
+0.1%
+56.09
Arrow-Thin-Down
NASDAQ
26,088.20
-0.7%
-185.92
Arrow-Thin-Down
Bitcoin
$80,624.00
-1.2%
-$1,000.35
Arrow-Thin-Down
AAPL
$294.80
+0.7%
+$2.12
Arrow-Thin-Down
AMZN
$265.79
-1.2%
-$3.20
Arrow-Thin-Down
GOOG
$383.99
-0.7%
-$2.78
Arrow-Thin-Down
META
$603.12
+0.7%
+$4.26
Arrow-Thin-Down
MSFT
$407.68
-1.2%
-$4.98
Arrow-Thin-Down
NVDA
$220.85
+0.6%
+$1.41
Arrow-Thin-Down
TSLA
$433.45
-2.6%
-$11.55
Most Active StocksDaily Stock GainersDaily Stock Losers
Hard To Treat Diseases logo

Hard To Treat Diseases

(OTC) HTDS

Current Price$0.00
Market Cap$5,500
Since IPO (2009)-100%
5 Year-100%
1 Year+0%
1 Month+0%

Hard To Treat Diseases Financials at a Glance

Market Cap

$5,500

Revenue (TTM)

N/A

Net Income (TTM)

N/A

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

10.91 (High)

Price

$0.00

Volume

275,000

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

HTDS News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Hard To Treat Diseases

Industry

Biotechnology

Sector

Health Care

Headquarters

Shenzhen, 518040, CN

HTDS Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

0%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

$5.50K

Shares Outstanding

5.48B

Volume

275.00K

Avg. Volume

380.61K

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Hard To Treat Diseases Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
CurrentYOY CHG

Revenue

N/A

N/A

Gross Profit

N/A

N/A

Gross Margin

N/A

N/A

Market Cap

$5.50K

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

N/A

N/A

EBITDA

N/A

N/A

Quarterly Fundamentals

Name
CurrentYOY CHG

Net Cash

N/A

N/A

Accounts Receivable

N/A

N/A

Inventory

N/A

N/A

Long Term Debt

N/A

N/A

Short Term Debt

N/A

N/A

Return on Assets

N/A

N/A

Return on Invested Capital

N/A

N/A

Free Cash Flow

N/A

N/A

Operating Cash Flow

N/A

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
PBLAPanbela Therapeutics, Inc.
$0.00+0.00%
RGMPRegnum Corp.
$0.00+0.00%
IMEXFImagin Medical Inc.
$0.00+0.00%
GBLXGB Sciences, Inc.
$0.00-25.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$120.61-0.07%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$15.96-0.05%
NOKNokia
$13.17-0.05%
TQQQProShares Trust - ProShares UltraPro Qqq
$74.96-0.03%

Questions About HTDS

What is the current price of Hard To Treat Diseases?

Hard To Treat Diseases is trading at N/A per share.

What is the 52-week range for Hard To Treat Diseases?

Over the past 52 weeks, Hard To Treat Diseases has traded between N/A and N/A.

How much debt does Hard To Treat Diseases have?

Hard To Treat Diseases total debt is unavailable.

How much cash does Hard To Treat Diseases have on hand?

Hard To Treat Diseases does not have cash on hand data available.

What is Hard To Treat Diseases’s dividend yield?

Hard To Treat Diseases does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services